Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
CAMBRIDGE, Mass., Feb. 21, 2012 (GLOBE NEWSWIRE) -- Pathfinder Cell Therapy, Inc. ("Pathfinder," or "the Company") (OTCQB:PFND), a biotechnology company focused on the treatment of diabetes and other...
-
CAMBRIDGE, Mass., Feb. 16, 2012 (GLOBE NEWSWIRE) -- Pathfinder Cell Therapy, Inc. ("Pathfinder," or "the Company") (OTCQB:PFND), a biotechnology company focused on the treatment of diseases...
-
CAMBRIDGE, Mass., Feb. 15, 2012 (GLOBE NEWSWIRE) -- Pathfinder Cell Therapy, Inc. ("Pathfinder," or "the Company") (OTCQB:PFND), a biotechnology company focused on the treatment of diseases...
-
CAMBRIDGE, Mass., Dec. 13, 2011 (GLOBE NEWSWIRE) -- Pathfinder Cell Therapy, Inc. ("Pathfinder") (OTCQB:PFND), a biotechnology company focused on the treatment of diseases characterized by...